搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Impacts
27 分钟
How Moderna is Changing the Biotech World
The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...
Impacts
1 小时
How Moderna’s Success is Changing the Biotech Industry
In recent years, the biotech industry has seen a lot of exciting changes, and much of that is thanks to one company: Moderna.
2 天
美国西北大学起诉Moderna侵犯LNP专利
作者:黄莺美国Moderna公司的专利官司持续不断。一周前,2024年10月12日,葛兰素史克公司(GSK)向美国特拉华州地方法院起诉Moderna,指控其COVID-19疫苗Spikevax以及今年5月份获得FDA批准的RNA呼吸道合胞病毒(RSV ...
4 天
葛兰素史克起诉Moderna侵犯mRNA专利的真实意图
作者:黄莺俗话说人红是非多。在新冠疫情期间,凭借mRNA疫苗大获成功的Moderna公司,从年营收只有几千万美元的公司,一举跨入年营收200亿美元的公司行列。而这为其也带来了越来越多的专利纠纷。2021年,Moderna与美国国立卫生研究院的mRNA ...
3 天
Moderna股价触及52周低点55.65美元,市场环境变化
Moderna ...
4 天
Northwestern sues Moderna for patent infringement over COVID-19 vaccines
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...
2 天
BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
Crain's Chicago Business
2 天
Moderna appropriated Northwestern research for COVID vaccine, lawsuit alleges
The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...
10 天
Moderna股价触及52周低点57.71美元,市场格局发生变化
在充满挑战的市场环境中,Moderna Inc. (MRNA)股价已触及52周低点,跌至57.71美元。这家以mRNA疫苗闻名的生物技术公司在过去一年经历了动荡,其股价反映出显著下滑。过去一年,Moderna股价下跌了42.71%,表明投资者情绪看空 ...
5 天
Moderna's Covid, RSV Vaccines Targeted in Two GSK Patent Suits
Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA ...
5 天
on MSN
GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines
GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK's patent rights in messenger ...
3 天
Moderna (MRNA) Receives a Hold from Jefferies
Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈